These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 33652858)

  • 1. Natural Products Targeting Amyloid Beta in Alzheimer's Disease.
    Lee JH; Ahn NH; Choi SB; Kwon Y; Yang SH
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer's Disease.
    Behl T; Kaur I; Fratila O; Brata R; Bungau S
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential therapeutic agents against Alzheimer's disease from natural sources.
    Park SY
    Arch Pharm Res; 2010 Oct; 33(10):1589-609. PubMed ID: 21052936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands.
    Iraji A; Khoshneviszadeh M; Firuzi O; Khoshneviszadeh M; Edraki N
    Bioorg Chem; 2020 Apr; 97():103649. PubMed ID: 32101780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Progress in the Drug Development for the Treatment of Alzheimer's Disease Especially on Inhibition of Amyloid-peptide Aggregation.
    Liu Y; Cong L; Han C; Li B; Dai R
    Mini Rev Med Chem; 2021; 21(8):969-990. PubMed ID: 33245270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibiting the Aggregation of Aβ by Natural Product Molecules.
    Bai SC; Wang YC; Li XZ; Li G
    ChemMedChem; 2024 Sep; 19(17):e202400223. PubMed ID: 38807345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAGE mediates Aβ accumulation in a mouse model of Alzheimer's disease via modulation of β- and γ-secretase activity.
    Fang F; Yu Q; Arancio O; Chen D; Gore SS; Yan SS; Yan SF
    Hum Mol Genet; 2018 Mar; 27(6):1002-1014. PubMed ID: 29329433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diplazium esculentum (Retz.) Sw. reduces BACE-1 activities and amyloid peptides accumulation in Drosophila models of Alzheimer's disease.
    Kunkeaw T; Suttisansanee U; Trachootham D; Karinchai J; Chantong B; Potikanond S; Inthachat W; Pitchakarn P; Temviriyanukul P
    Sci Rep; 2021 Dec; 11(1):23796. PubMed ID: 34893659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
    Savelieff MG; DeToma AS; Derrick JS; Lim MH
    Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin Facilitates Amyloid-β Generation by β- and γ-Secretases via Autophagy Activation.
    Son SM; Shin HJ; Byun J; Kook SY; Moon M; Chang YJ; Mook-Jung I
    J Alzheimers Dis; 2016; 51(4):1197-208. PubMed ID: 26967226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flavanone glycosides inhibit β-site amyloid precursor protein cleaving enzyme 1 and cholinesterase and reduce Aβ aggregation in the amyloidogenic pathway.
    Ali MY; Jannat S; Edraki N; Das S; Chang WK; Kim HC; Park SK; Chang MS
    Chem Biol Interact; 2019 Aug; 309():108707. PubMed ID: 31194956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Structure and Function of α, β and γ-Secretase as Therapeutic Target Enzymes in the Development of Alzheimer's Disease: A Review.
    Ahmad SS; Khan S; Kamal MA; Wasi U
    CNS Neurol Disord Drug Targets; 2019; 18(9):657-667. PubMed ID: 31608840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease-modifying therapies in Alzheimer's disease: how far have we come?
    Hüll M; Berger M; Heneka M
    Drugs; 2006; 66(16):2075-93. PubMed ID: 17112302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Y
    Matrone C; Iannuzzi F; Annunziato L
    Ageing Res Rev; 2019 Jul; 52():120-128. PubMed ID: 31039414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breaker peptides against amyloid-β aggregation: a potential therapeutic strategy for Alzheimer's disease.
    Ghosh N; Kundu LM
    Future Med Chem; 2021 Oct; 13(20):1767-1794. PubMed ID: 34498978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BIIB042, a novel γ-secretase modulator, reduces amyloidogenic Aβ isoforms in primates and rodents and plaque pathology in a mouse model of Alzheimer's disease.
    Scannevin RH; Chollate S; Brennan MS; Snodgrass-Belt PA; Peng H; Xu L; Jung MY; Bussiere T; Arastu MF; Talreja T; Xin Z; Dunstan RW; Fahrer D; Rohde E; Dunah AW; Wang J; Kumaravel G; Taveras AG; Moore Arnold H; Rhodes KJ
    Neuropharmacology; 2016 Apr; 103():57-68. PubMed ID: 26690893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a BACE1 Binding Peptide Candidate for the Prevention of Amyloid Beta in Alzheimer's Disease.
    Read J; Suphioglu C
    Cell Physiol Biochem; 2019; 53(2):413-428. PubMed ID: 31415717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining an amyloid-beta (Aβ) cleaving enzyme inhibitor with a γ-secretase modulator results in an additive reduction of Aβ production.
    Strömberg K; Eketjäll S; Georgievska B; Tunblad K; Eliason K; Olsson F; Radesäter AC; Klintenberg R; Arvidsson PI; von Berg S; Fälting J; Cowburn RF; Dabrowski M
    FEBS J; 2015 Jan; 282(1):65-73. PubMed ID: 25303711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-functional activities of citrus flavonoid narirutin in Alzheimer's disease therapeutics: An integrated screening approach and in vitro validation.
    Chakraborty S; Basu S
    Int J Biol Macromol; 2017 Oct; 103():733-743. PubMed ID: 28528948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.